Pharmaroth Labs Inc. (ROTH)
EXPM EXPM Primary Summary
Pharmaroth Labs Inc. (ROTH) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Pharmaroth Labs Inc. ever had a stock split?
Pharmaroth Labs Inc. Profile
| Pharmaceuticals Industry | Healthcare Sector | Luis Manuel Ornelas Lopez CEO | EXPM Exchange | 71715Y102 CUSIP |
| US Country | - Employees | - Last Dividend | 1 Jun 2010 Last Split | - IPO Date |
Overview
PharmaRoth Labs, Inc. is an established nutraceutical company that operates on a global scale, committed to the production, marketing, and distribution of specialized nutraceutical products. Initially known as Fero Industries Inc., the company underwent a name change to PharmaRoth Labs, Inc. in March 2013, marking a significant pivot in its strategic direction. Since its foundation in 2000, PharmaRoth Labs has rooted its operations in Las Vegas, Nevada, where it continues to innovate within the nutraceutical space. Their corporate mission centers around leveraging herbal-based treatments to address complex health conditions, specifically type-2 diabetes, demonstrating a unique blend of traditional knowledge and modern scientific approaches.
Products and Services
The cornerstone of PharmaRoth Labs, Inc.'s product offering is:
- Sucanon: This is an herbal-based nutraceutical treatment designed for individuals living with type-2 diabetes. Sucanon represents the amalgamation of traditional herbal knowledge with contemporary scientific research, providing a natural alternative or supplement to conventional diabetes treatments. Its formulation is specially designed to help manage blood sugar levels, offering a holistic approach to diabetes management. PharmaRoth Labs, Inc. positions Sucanon at the forefront of their product line, underscoring their commitment to innovative, natural health solutions.
